Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls

10th September 2019 Uncategorised 0

Catalent has invested $9 million in a clinical supply facility and Sagent has access to expanded manufacturing in Canada from its parent.

More: Manufacturing News of Note: Catalent expands; Hospira and Novartis issue recalls
Source: fierce